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Introduction {#aos14256-sec-0005}
============

Infectious keratitis is an acute and potentially sight‐threatening infection of the cornea that can lead to permanent, severe sight loss. A common predisposing risk factor in individuals with otherwise healthy eyes is contact lens wear (CLW) (Dart et al. [1991](#aos14256-bib-0003){ref-type="ref"}; Erie et al. [1993](#aos14256-bib-0004){ref-type="ref"}; Ladage et al. [2001](#aos14256-bib-0009){ref-type="ref"}; Bourcier et al. [2003](#aos14256-bib-0002){ref-type="ref"}; Keay et al. [2006](#aos14256-bib-0008){ref-type="ref"}; Stapleton & Carnt [2012](#aos14256-bib-0017){ref-type="ref"}). It has been suggested that the posterior contact lens surface enables biofilm formation that makes known corneal pathogens such as *Pseudomonas aeruginosa* more resistant to the antibacterial effects of the tear film and the defence mechanisms of the immune system (Tam et al. [2010](#aos14256-bib-0019){ref-type="ref"}).

The surface of the eye consists of the cornea and the conjunctiva. The conjunctiva communicates with the mucous membrane of the nose via the lacrimal sac. Under normal circumstances, the surface of the eye is colonized with commensals such as coagulase‐negative staphylococci (CoNS), *Corynebacterium* spp. and *Propionibacterium* spp. (Fleiszig & Efron [1992](#aos14256-bib-0005){ref-type="ref"}; Willcox [2013](#aos14256-bib-0020){ref-type="ref"}). The microbiology of infectious keratitis is well studied but there are conflicting data in the literature regarding the rate of positive corneal cultures and the most commonly isolated microbes (Bourcier et al. [2003](#aos14256-bib-0002){ref-type="ref"}; Yeh et al. [2006](#aos14256-bib-0021){ref-type="ref"}; Green et al. [2008](#aos14256-bib-0006){ref-type="ref"}; Lichtinger et al. [2012](#aos14256-bib-0010){ref-type="ref"}; Hoddenbach et al. [2014](#aos14256-bib-0007){ref-type="ref"}).

In a previous study of all hospitalized cases of contact lens induced keratitis in Sweden during 1989--1991(Nilsson & Montan [1994](#aos14256-bib-0014){ref-type="ref"}), bacterial growth was found in 54% of the patients. Among the most commonly isolated bacteria reported were *P. aeruginosa* (24%), *Staphylococcus epidermidis* (10%) and *Staphylococcus aureus* (6%). *Acanthamoeba* was isolated in 6% of the patients. There is another Swedish study from the same time period, prospectively including all cases, both contact lens induced and not, of infectious keratitis presenting in the greater Gothenburg region(Neumann & Sjostrand [1993](#aos14256-bib-0012){ref-type="ref"}). In this study, corneal cultures were positive in 46% (22/48) of the patients. *Pseudomonas* was isolated in 6% (3/48), *S. epidermidis* in 8% (4/48) and *S. aureus* in 13% (6/48) of the corneal cultures.

There are no recent studies from Sweden describing the causative microorganisms and their antibiotic susceptibility pattern in infectious keratitis. Since antimicrobial therapy needs to be initiated before the results of the corneal cultures are available, knowledge of the spectrum of causative micro‐organisms and their antibiotic susceptibility pattern is vital when choosing adequate empiric treatment for patients with infectious keratitis.

The aim of the present study was to describe predisposing risk factors, isolated micro‐organism and their antibiotic susceptibility pattern, in patients with infectious keratitis treated in a region in the central part of Sweden.

Materials and Methods {#aos14256-sec-0006}
=====================

Study population {#aos14256-sec-0007}
----------------

This is a descriptive study conducted as a retrospective audit of clinical records and microbiological reports. The study was approved by the Regional Ethical Review Board of Uppsala (No 2015/335). Patients eligible for inclusion were identified through two pathways; a database search for keratitis (diagnosis code H16.9 in the International Classification of Disease, version 10) was performed at the three ophthalmology departments in Region Örebro County: at Örebro University Hospital, Karlskoga County Hospital, and Lindesberg County Hospital between 1 January 2004 and 31 December 2014, and a search of the database at the Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, was performed to identify all patients who had undergone corneal culture during the study period (Fig. [1](#aos14256-fig-0001){ref-type="fig"}). Patients undergoing corneal culture due to presumed infectious keratitis were included if they met at least one of two inclusion criteria (Stapleton et al. [2012](#aos14256-bib-0018){ref-type="ref"}); (1) positive corneal culture (all growth was considered positive); (2) and/or stromal infiltration with overlying epithelial defect in combination with at least one of the following; lesion within or overlapping the central 4 mm of the cornea and/or uveitis and/or pain.

![Study population: Flow chart showing how corneal cultured patients with infectious keratitis were identified during the 11‐year study period (2004--2014). Database search for diagnosis code H16.9 in the International Classification of Disease version 10 (ICD10) at the three ophthalmology departments in Region Örebro County, Sweden; database search at the Department of Laboratory Medicine, Clinical Microbiology (DLMCM), Örebro University Hospital, Sweden; or both.](AOS-98-255-g001){#aos14256-fig-0001}

Microbiological cultures {#aos14256-sec-0008}
------------------------

Corneal cultures were performed by either an ophthalmologist or a resident within ophthalmology according to written instructions available at the relevant time period. These written instructions were in accordance with the Swedish State of the Art Document on Infectious Keratitis Caused by Bacteria, Yeast, and Protozoa ([2002](#aos14256-bib-0001){ref-type="ref"}) and can be considered to describe a routine procedure.

Prior to sampling, topical preservative‐free anaesthesia was applied. Microbial/bacterial samples were collected according to the following standard procedures. Samples from the infiltrates were obtained with both sterile cotton tipped applicators and a sterile number 15 knife blade. The corneal samples were inoculated on gonococcal agar, blood agar and Sabouraud agar and in fastidious anaerobic broth. If any clinical suspicion of *Acanthamoeba*, a final scraping in Page\'s saline solution or sodium chloride solution 0.9% was performed and sent to the national reference laboratory at the Public Health Agency of Sweden for further culture.

Typing of isolated microbes was carried out with Analytical Profile Index kits or with matrix‐assisted laser desorption/‐ionization time‐of‐flight mass spectrometry. Antibiotic susceptibility patterns were determined by the disc diffusion method or a gradient test such as the *E*‐test, according to the guidelines of the Swedish Reference Group of Antibiotic Issues (RAF; [www.sls.se/raf](www.sls.se/raf)) and later of the European Committee on Antimicrobial Susceptibility Testing (EUCAST; [www.eucast.org](www.eucast.org)). In this study, both I and R according to Susceptible Intermediate Resistant (SIR) system (EUCAST) are reported as reduced susceptibility, and not reported separately. Since the Department of Ophthalmology at the University Hospital of Örebro is a tertiary ophthalmology referral centre, some of the patients included in this study (*n* = 16) were cultured at ophthalmological departments other than the three in Region Örebro County. These cultures may not have been performed according to the method described above.

Statistical analyses were calculated in version 22 of IBM (Armonk, NY, USA) SPSS, using Pearson\'s chi‐square test or Fisher\'s exact test as appropriate. A significance level of p \< 0.05 was chosen.

Results {#aos14256-sec-0009}
=======

Study population {#aos14256-sec-0010}
----------------

During the 11 year study period, 392 patients with 398 episodes of infectious keratitis were included. Three women and three men had two separate episodes each.

Almost 10% of the study population (41 patients with 42 episodes) was referred from ophthalmology departments outside Region Örebro County. The remaining 351 patients, comprising 356 episodes, were inhabitants of Örebro County; six of these were initially diagnosed and treated elsewhere.

The median age was 49.5 years, ranging from 5 to 98 years. The study population consisted of 57% women, and 51.5% of episodes were in right eye. Additional surgical intervention and/or corneal cross‐linking (CXL) was performed in 27% (104/391) of the included patients. For one patient, it is unknown whether additional treatment was performed or not and another six patients are excluded from these calculations since they were involved in a prospective study of CXL as primary intervention (Makdoumi et al. [2012](#aos14256-bib-0011){ref-type="ref"}) ([1](#aos14256-tbl-0001){ref-type="table"}).

###### 

Patients with infectious keratitis requiring additional intervention in relation to corneal culture outcome

                                                              Total   AMT only   CXL only   CT only   Evisc/Enuc only   AMT + CXL   AMT + CT   CT + CXL   CXL + Evisc/Enuc   AMT + CXL + Evisc/Enuc   AMT + CT + CXL   CT + CXL + Evisc/Enuc
  ----------------------------------------------------------- ------- ---------- ---------- --------- ----------------- ----------- ---------- ---------- ------------------ ------------------------ ---------------- -----------------------
  Culture positive (*n* = 278)                                84      22         20         5         1                 20          4          3          4                  2                        2                1
  Culture negative (*n* = 113)                                20      9          2          0         2                 5           0          0          1                  0                        1                0
  Total[\*](#aos14256-note-0003){ref-type="fn"} (*n* = 391)   104     31         22         5         3                 25          4          3          5                  2                        3                1

AMT = amniotic membrane transplant; CT = corneal transplant; CXL = corneal cross‐linking; Evisc./Enuc. = Evisceration/Enucleation.

\* For one patient with positive corneal culture, it is unknown whether an additional intervention was performed or not. Six patients that at the study period was involved in another study (Makdoumi et al. [2012](#aos14256-bib-0011){ref-type="ref"}) regarding CXL as primary treatment of bacterial keratitis are excluded from these calculations.
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Culture outcome {#aos14256-sec-0011}
---------------

Of the 398 episodes, 285 (71.6%) were culture positive, of these 98% (279/285) had pure bacterial growth, and 2% (6/285) growth of fungi of which three had pure growth of fungi, and three in combination with bacterial growth of anaerobe microbes: *Cutibacterium acnes (formerly Propionibacterium acnes)* and anaerobe Gram‐positive cocci. Despite 124 corneal cultures for *Acanthamoeba* during the study period of 11 years, there were no findings of the protozoa in the study group.

However, in the retrospective audit of medical journals, one case with a documented persisting clinical suspicion of *Acanthamoeba*, despite negative culture was identified. Polymerase Chain Reaction and confocal microscopy were not performed. The patient, a contact lens wearer, was in severe pain and did not respond to treatment with topical fluoroquinolones, or fortified drops of vancomycin and ceftazidime. Improvement was noted after a couple of days treatment with chlorhexidine in combination with tobramycin.

The most common risk factor for infectious keratitis, regardless of whether the corneal cultures were positive or not, was contact lens wear which was seen in 44.5% (127/285) of those with positive cultures and in 47.8% (54/113) of those with negative cultures (Table [2](#aos14256-tbl-0002){ref-type="table"}).

###### 

Predisposing risk factors, prevalence of previous antibiotic treatment prior to culture and corneal culture outcome in patients with infectious keratitis

<table><thead><tr class="header"><th> </th><th>Total</th><th>CLW</th><th>No known</th><th>OSD</th><th>OT</th><th>Corneal transplant</th><th>Eyelid disorder</th><th>Blind/severely diseased eye</th><th>Other ocular surgery</th></tr></thead><tbody><tr class="odd"><td>Total</td><td>398</td><td>181</td><td>76</td><td>43</td><td>32</td><td>28</td><td>22</td><td>9</td><td>7</td></tr><tr class="even"><td><p>Culture positive (% of total in group)</p><p>(No prior antibiotic/prior antibiotic)</p></td><td><p>285<a href="#aos14256-note-0006" data-ref-type="fn">*</a> (72%)</p><p>(236/48)</p></td><td><p>127<a href="#aos14256-note-0006" data-ref-type="fn">*</a> (70%)</p><p>(113/13)</p></td><td><p>54 (71%)</p><p>(46/8)</p></td><td><p>29 (67%)</p><p>(24/5)</p></td><td><p>22 (69%)</p><p>(13/9)</p></td><td><p>25 (89%)</p><p>(21/4)</p></td><td><p>17 (77%)</p><p>(12/5)</p></td><td><p>7 (78%)</p><p>(5/2)</p></td><td><p>4 (57%)</p><p>(2/2)</p></td></tr><tr class="odd"><td>Polymicrobial growth [% of culture positive in group]</td><td>77<a href="#aos14256-note-0006" data-ref-type="fn">*</a> [27%]</td><td>26<a href="#aos14256-note-0006" data-ref-type="fn">*</a> [20%]</td><td>21 [39%]</td><td>6 [21%]</td><td>6 [27%]</td><td>10 [40%]</td><td>7 [41%]</td><td>1 [14%]</td><td>0 [0%]</td></tr><tr class="even"><td><p>Culture negative (% of total in group)</p><p>(No prior antibiotic/prior antibiotic)</p></td><td><p>113 (28%)</p><p>(86/27)</p></td><td><p>54 (30%)</p><p>(49/5)</p></td><td><p>22 (29%)</p><p>(19/3)</p></td><td><p>14 (33%)</p><p>(9/5)</p></td><td><p>10 (31%)</p><p>(6/4)</p></td><td><p>3 (11%)</p><p>(1/2)</p></td><td><p>5 (23%)</p><p>(1/4)</p></td><td><p>2 (22%)</p><p>(0/2)</p></td><td><p>3 (43%)</p><p>(1/2)</p></td></tr></tbody></table>

Corneal transplant: Penetrating keratoplasty, DSAEK, Superficial lamellar keratoplasty. Eyelid disorder: closure defect, trachoma, entropion, ectropion. Percentages within parentheses () refer to the proportions of culture positive and culture negative cases, respectively, in the respective risk factor group. Percentages within square brackets \[\] refer to the proportion of polymicrobial growth, in the respective risk factor groups of positive corneal culture cases.

CLW = contact lens wear; OSD = ocular surface disease; OT = ocular trauma.

\* For one patient, it was unknown whether antibiotic treatment had been initiated prior to sampling.
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The most commonly isolated microorganisms among the 285 positive corneal cultures were CoNS (39.6%, *n* = 113) and anaerobic diphtheroid rods (25.6%, *n* = 73), predominantly *C. acnes* (Table [3](#aos14256-tbl-0003){ref-type="table"}). *S. aureus* (15.1%, *n* = 43) was the most frequently isolated microbe among the Gram‐positives not considered a commensal. *Moraxella* spp. (7.4%, *n* = 21) and *P. aeruginosa* (6.7%, *n* = 19) were among the most commonly isolated Gram‐negative bacteria.

###### 

Corneal culture findings in relation to predisposing risk factor in patients with infectious keratitis

                                                              Total                                                              CLW      NK       OSD      OT       CT       ELD      SI/B     OOS      
  ----------------------------------------------------------- ------------------------------------------------------------------ -------- -------- -------- -------- -------- -------- -------- -------- ----
  All microbes isolated                                       378                                                                156      83       37       30       36       24       8        4        
  Gram‐positive                                               *Staphylococcus aureus*                                            43       10       11       8        6        5        2        --       1
  Coagulase‐negative staphylococci                            113                                                                49       26       7        10       10       9        1        1        
  *Streptococcus pneumoniae*                                  9                                                                  1        1        4        1        1        --       1        --       
  Alpha‐haemolytic streptococci                               24                                                                 6        4        4        6        3        1        --       --       
  Beta‐haemolytic streptococci                                4                                                                  1        2        1        --       --       --       --       --       
  *Corynebacterium* spp.                                      34                                                                 13       8        5        --       5        2        1        --       
  *Micrococcus* spp.                                          5                                                                  1        1        1        --       --       --       --       2        
  Miscellaneous[\*](#aos14256-note-0008){ref-type="fn"}       3                                                                  1        2        --       --       --       --       --       --       
  **Total Gram‐positive**                                     **235**                                                            **82**   **55**   **30**   **23**   **24**   **14**   **3**    **4**    
  Gram‐negative                                               *Haemophilus influenzae*                                           4        1        --       --       --       1        1        1        --
  *Moraxella* spp.                                            21                                                                 2        10       2        1        2        2        2        --       
  *Neisseria meningitidis*                                    3                                                                  3        --       --       --       --       --       --       --       
  *Pseudomonas aeruginosa*                                    19                                                                 16       --       --       --       1        2        --       --       
  Enterobacteriaceae[†](#aos14256-note-0009){ref-type="fn"}   9                                                                  5        --       --       --       1        2        1        --       
  Miscellaneous[‡](#aos14256-note-0010){ref-type="fn"}        6                                                                  2        1        2        1        --       --       --       --       
  **Total Gram‐negative**                                     **62**                                                             **29**   **11**   **4**    **2**    **5**    **7**    **4**    **--**   
  Anaerobes                                                   Anaerobic diphteroid rods[§](#aos14256-note-0011){ref-type="fn"}   73       41       16       3        4        6        3        --       --
  Anaerobic Gram‐positive cocci                               2                                                                  1        1        --       --       --       --       --       --       
  **Total anaerobes**                                         **75**                                                             **42**   **17**   **3**    **4**    **6**    **3**    **--**   **--**   
  Fungi                                                       *Candida albicans*                                                 2        1        --       --       --       1        --       --       --
  Miscellaneous[¶](#aos14256-note-0012){ref-type="fn"}        4                                                                  2        --       --       1        --       --       1        --       
  **Total fungi**                                             **6**                                                              **3**    **--**   **--**   **1**    **1**    **--**   **1**    **--**   

CLW = contact lens wear; CT = corneal transplant; ELD = eye lid disorder; NK = no known; OOS = other ocular surgery; OSD = ocular surface disease; OT = ocular trauma; SI/B = severely ill/blind eye.

\* Miscellaneous *Bacillus* spp., *Clostridium* spp.

^†^ Enterobacteriaceae *Serratia* spp., *Escherichia coli*,*Enterobacteriaceae* spp. *Klebsiella oxytoca*,*Proteus mirabilis*.

^‡^ Miscellaneous *Aggregatibacter segnis*,*Stenotrophomonas maltophilia*,*Chrysoebacterium indologenes*,*Pasteurella multocida*. *Pseudomonas* spp., Gram‐negative rod not specified.

^§^ Anaerobic diphteroid rods: *Cutibacterium acnes*, anaerobic diphteroid rods.

^¶^ Miscellaneous: *Aspergillus fumigatus*,*Alternaria* spp., *Fusarium spp*., mould non‐specified.
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There was no statistically significant difference (p = 0.11, chi‐square test) in corneal culture outcome between the group that was cultured prior to antibiotic treatment compared to the group that was cultured after initial treatment. However, a statistically significantly higher number of cultures with polymicrobial growth were detected in the group not treated with antibiotics prior to culture (30.1%, 71/236) in comparison with those treated with antibiotics prior to culture (10.4%, 5/48; p = 0.005, chi‐square test). For one patient, there was no information on whether culture had been taken prior to antibiotic treatment; this patient had a history of contact lens wear and had polymicrobial growth with two different microbes.

In 75 patients, the corneal culture was preceded by antibiotic treatment. Fluoroquinolones in 21 cases of which 6 were culture negative, fusidic acid in 18 cases of which 7 were culture negative, chloramphenicol in 16 cases of which six were culture negative and a combination of fluoroquinolones and chloramphenicol in 10 cases of which four were culture negative. Remaining 10 patients were treated with polymyxin B, bibrocathol, tobramycin, or a combination of fusidic acid and chloramphenicol, fluoroquinolones and cefuroxime, or fluoroquinolones and fusidic acid.

The mean duration of combination treatment with topical chloramphenicol and fluoroquinolones prior to culture in the six patients with positive corneal culture was 3.5 days (range: 1--8 days). All six patients with a positive corneal culture after initial treatment with a combination of chloramphenicol and fluoroquinolones had pure growth of one microbe each; three with *C. acnes*, of which one had no reduced susceptibility and in the other two antibiotic susceptibility testing, was not performed. The forth patient, a contact lens wearer, had growth of *P. aeruginosa* -- susceptible to ciprofloxacin and levofloxacin, this patient needed an amniotic membrane transplant. The fifth patient had growth with *Proteus mirabilis* -- susceptible to ciprofloxacin. This was a previously blind eye due to secondary glaucoma and the eye was eviscerated. The sixth patient had growth of CoNS, susceptible to levofloxacin, ciprofloxacin and chloramphenicol. This patient had ocular surface disease and needed an amniotic membrane transplant and tarsorrhaphy.

Antibiotic susceptibility pattern {#aos14256-sec-0012}
---------------------------------

Reduced susceptibility to fluoroquinolones was seen in 5/43 (12%) of *S. aureus* isolates and in 4/9 (44%) of *Streptococcus pneumoniae* isolates. One of the *S. aureus* isolates with reduced susceptibility was treated with clindamycin prior to culture. Determination of Minimum Inhibitory Concentration (MIC) level was carried out in one of the isolated *S. pneumonia* and was determined to 0.5 mg/L. The remaining three isolates were I according to the SIR system (EUCAST.org).

Reduced susceptibility to ceftazidime was seen in 1/43 (2%) of *S. aureus* isolates.

One *Pseudomonas* sp. isolate (5%) showed reduced susceptibility to gentamicin which was from a patient who had not been treated with antibiotics prior to culture. Reduced susceptibility to tobramycin was seen in 1/4 (25%) isolates of beta‐haemolytic streptococci; this patient was not treated with antibiotics prior to culture.

Among the yeasts, one of two *Candida albicans* isolates showed reduced susceptibility to fluconazole (MIC 4 mg/L). This patient had received levofloxacin prior to corneal culture.

Discussion {#aos14256-sec-0013}
==========

During 2004--2014, we identified and included 392 patients with 398 episodes of infectious keratitis. Coagulase‐negative staphylococci (CoNS), *S. aureus* and *P. aeruginosa* were among the most frequently isolated microbes which was also the case in the previous two Swedish studies from the 90s (Neumann & Sjostrand [1993](#aos14256-bib-0012){ref-type="ref"}; Nilsson & Montan [1994](#aos14256-bib-0014){ref-type="ref"}).

Our results regarding the predominantly isolated bacteria and frequency of polymicrobial growth are also similar to those reported by Yeh et al. ([2006](#aos14256-bib-0021){ref-type="ref"}) from North Carolina, USA with a similar study design as ours. Bourcier et al. ([2003](#aos14256-bib-0002){ref-type="ref"}) in Paris, France, also reported similar results, with a frequency of CoNS in 48% (100/207) and *P. aeruginosa* in 10% (21/207) of those with positive cultures.

Comparisons between studies are difficult since frequencies of isolated microbes are reported in different ways. We have chosen to report the frequency of isolated microbes in relation to all culture positive cases. Prevalence of risk factors, climate and study design may also influence the results.

During 11 years not a single isolate of *Acanthamoeba* was detected despite 124 cultures was performed, and a high prevalence of contact lens wearers were present in the study group. Our lack of positive cultures for *Acanthamoeba*, and only one documented case with a persisting clinical suspicion of *Acanthamoeba* despite negative culture, are in contrast to previously findings from the early 90s by Skarin et al. They reported eight cases of verified *Acanthamoeba* during 2 years in the south of Sweden (Skarin et al. [1996](#aos14256-bib-0016){ref-type="ref"}). We have no explanation for this, but the study periods are more than 10 years apart. Differences in contact lens hygiene routines and contact lens wear schedule may among other factors, such as the method of corneal sampling, be different between the present study population and the one reported by Skarin et al.

The low rate of fungi in our study 2% (6/285) is similar to the study by Hoddenbach et al. ([2014](#aos14256-bib-0007){ref-type="ref"}) who found 2% (1/59) of fungi in corneal cultures from patients admitted to hospital for treatment of contact lens related keratitis. In Denmark, Nielsen et al. ([2015](#aos14256-bib-0013){ref-type="ref"}) reported 25 cases of fungal keratitis during 14 years giving an incidence of 0.6 per million per year. They found a significant delay of 24 days before correct diagnosis (Nielsen et al. [2015](#aos14256-bib-0013){ref-type="ref"}). In our study, a correct diagnosis was delayed in one‐third of the patients with growth of fungi since two of the patients with growth of fungi were cultured after an initial treatment with antibiotics.

The frequency of positive corneal cultures in our study (72%) was at the higher end of the frequencies previously reported in the literature. This might be due to our sampling method but could also be due to our definition of positive culture. In terms of positive or negative culture outcome, there was no statistically significant difference between patients treated with antibiotics prior to culture and those who were not. This might be due to patient compliance with local eye drops/ointment, or to selection bias. The finding of three positive cultures with aerobic microbes sensitive to fluoroquinolones, chloramphenicol or both despite that treatment with these two antibiotics preceded the corneal culture indicate that compliance and other mechanism, not fully understood may be involved. The lower rate of polymicrobial growth among the patients cultured after prior antibiotic treatment compared to those cultured prior to treatment was however statistically significant. This might be due to the effect of antibiotic treatment on some of the susceptible microorganisms, but might also be due to the fact that antibiotic treatment alters the bacterial load on the conjunctiva and eyelids, resulting in less contamination from commensal bacteria.

Our results revealed a low frequency (5%) of reduced susceptibility to gentamicin among isolated *P. aeruginosa*. This is consistent with the findings by Yeh et al. ([2006](#aos14256-bib-0021){ref-type="ref"}) Lichtinger et al. ([2012](#aos14256-bib-0010){ref-type="ref"}) and Sand et al. ([2015](#aos14256-bib-0015){ref-type="ref"}). None of the *S. aureus* isolates in our study were methicillin resistant (MRSA). This finding is similar to the reported frequency of 1.3% MRSA in Toronto (Lichtinger et al. [2012](#aos14256-bib-0010){ref-type="ref"}), but in contrast to a reported frequency of 44% in Los Angeles (Sand et al. [2015](#aos14256-bib-0015){ref-type="ref"}).

The absence of MRSA in our study may reflect its low prevalence in the Nordic countries. In Sweden for instance, every case of MRSA is retraced in order to prevent further spread, antibiotic prescription is restricted, and strict hygiene measures are in place at all healthcare facilities.

We chose to apply the criteria of Stapleton et al. ([2012](#aos14256-bib-0018){ref-type="ref"}) with both clinical and laboratory criterion to define an episode of infectious keratitis. Clinical course and risk factors for infectious keratitis are not included in this definition. The clinical relevance of corneal culture findings in patients with infectious keratitis is difficult to interpret. Small sample size may result in false‐negative cultures. Since the surface of the eye under normal circumstances is not sterile, there is always a risk of false‐positive cultures. In a clinical setting, the clinical presentation, disease course, local and systemic risk factors guide us in the interpretation of a corneal culture result in a patient with suspected infectious keratitis.

The strengths of this study are the size of the study group, with a relatively high number of positive corneal cultures and the likelihood of only few missing cases, since we identified cases both by diagnosis code and via the database at the Department of Laboratory Medicine.

The major limitation of this study is its retrospective design. Information in the medical records and microbiology reports are not always complete. Furthermore, since the culture findings had to be interpreted retrospectively the relation to the clinical course and local and systemic risk factors was challenging to take account for.

In conclusion, among the most common microbes, not considered commensals, isolated from the cornea in microbial keratitis were *S. aureus, Moraxella* spp. and *P. aeruginosa*. Contact lens wear was the most common predisposing risk factor. The antibiotic susceptibility patterns showed low frequency of resistance. Consequently, due to the spectrum of isolated microbes and their antibiotic susceptibility pattern, empiric treatment in a setting like ours, a combination of topical fluoroquinolones and chloramphenicol could be considered as an appropriate treatment for bacterial keratitis pending corneal culture results.
